scholarly journals UV-Responsive Screen-Printed Porous ZnO Nanostructures on Office Paper for Sustainable and Foldable Electronics

Chemosensors ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 192
Author(s):  
Sofia Henriques Ferreira ◽  
Inês Cunha ◽  
Joana Vaz Pinto ◽  
Joana Pereira Neto ◽  
Luís Pereira ◽  
...  

The fabrication of low-cost, flexible, and recyclable electronic devices has been the focus of many research groups, particularly for integration in wearable technology and the Internet of Things (IoT). In this work, porous zinc oxide (ZnO) nanostructures are incorporated as a UV sensing material into the composition of a sustainable water-based screen-printable ink composed of carboxymethyl cellulose (CMC). The formulated ink is used to fabricate flexible and foldable UV sensors on ubiquitous office paper. The screen-printed CMC/ZnO UV sensors operate under low voltage (≤2 V) and reveal a stable response over several on/off cycles of UV light exposure. The devices reach a response current of 1.34 ± 0.15 mA and a rise and fall time of 8.2 ± 1.0 and 22.0 ± 2.3 s, respectively. The responsivity of the sensor is 432 ± 48 mA W−1, which is the highest value reported in the literature for ZnO-based UV sensors on paper substrates. The UV-responsive devices display impressive mechanical endurance under folding, showing a decrease in responsivity of only 21% after being folded 1000 times. Their low-voltage operation and extreme folding stability indicate a bright future for low-cost and sustainable flexible electronics, showing potential for low-power wearable applications and smart packaging.

Micromachines ◽  
2019 ◽  
Vol 10 (9) ◽  
pp. 601 ◽  
Author(s):  
Joana Figueira ◽  
Cristina Gaspar ◽  
José Tiago Carvalho ◽  
Joana Loureiro ◽  
Elvira Fortunato ◽  
...  

Low-cost and large-scale production techniques for flexible electronics have evolved greatly in recent years, having great impact in applications such as wearable technology and the internet of things. In this work, we demonstrate fully screen-printed UV photodetectors, successfully fabricated at a low temperature on a cork substrate, using as the active layer a mixture of zinc oxide nanoparticles and ethylcellulose. The photoresponse under irradiation with a UV lamp with peak emission at 302 nm exhibited a quasi-quadratic behavior directly proportional to the applied voltage, with a photocurrent of about 5.5 and 20 μA when applying 1.5 V and 5 V, respectively. The dark current stayed below 150 nA, while the rise and falling times were, respectively, below 5 and 2 s for both applied voltages. The performance was stable over continuous operation and showed a degradation of only 9% after 100 bending cycles in a 45 mm radius test cylinder. These are promising results regarding the use of this type of sensor in wearable applications such as cork hats, bracelets, or bags.


2011 ◽  
Vol 299-300 ◽  
pp. 659-662 ◽  
Author(s):  
Lei Xin Meng ◽  
Lian Zhu Zhang

UV (ultraviolet) sensor is widely used in many fields such as missile early warning, spacecraft autonomous navigation, global positioning and so on. Comparing with other semiconductor based UV sensor, ZnO nanowire (NW) UV sensor have many unique advantages including visual light blind, biocompatible, low cost and so on. But, two main shortages, low photo response () and long recover time, embarrass the application of single wire ZnO UV sensor. In this paper, we introduce the working principle of ZnO NW UV sensor and expound some methods for increasing photo response, enhancing sensitivity and shortening response and reset time of ZnO NW UV sensor. Besides this, we introduce a kind of UV sensor fabricated by integrated ZnO NWs recently. The photo response of this UV sensors reaches the order of mA, when exposed to UV light at 4.5 mW/cm2. It also has perfect stability and reliability. Because of these properties, this new kind of UV sensors has a great potential for application.


2018 ◽  
Vol 10 (470) ◽  
pp. eaau1643 ◽  
Author(s):  
Seung Yun Heo ◽  
Jeonghyun Kim ◽  
Philipp Gutruf ◽  
Anthony Banks ◽  
Pinghung Wei ◽  
...  

Exposure to electromagnetic radiation can have a profound impact on human health. Ultraviolet (UV) radiation from the sun causes skin cancer. Blue light affects the body’s circadian melatonin rhythm. At the same time, electromagnetic radiation in controlled quantities has beneficial use. UV light treats various inflammatory skin conditions, and blue light phototherapy is the standard of care for neonatal jaundice. Although quantitative measurements of exposure in these contexts are important, current systems have limited applicability outside of laboratories because of an unfavorable set of factors in bulk, weight, cost, and accuracy. We present optical metrology approaches, optoelectronic designs, and wireless modes of operation that serve as the basis for miniature, low-cost, and battery-free devices for precise dosimetry at multiple wavelengths. These platforms use a system on a chip with near-field communication functionality, a radio frequency antenna, photodiodes, supercapacitors, and a transistor to exploit a continuous accumulation mechanism for measurement. Experimental and computational studies of the individual components, the collective systems, and the performance parameters highlight the operating principles and design considerations. Evaluations on human participants monitored solar UV exposure during outdoor activities, captured instantaneous and cumulative exposure during blue light phototherapy in neonatal intensive care units, and tracked light illumination for seasonal affective disorder phototherapy. Versatile applications of this dosimetry platform provide means for consumers and medical providers to modulate light exposure across the electromagnetic spectrum in a way that can both reduce risks in the context of excessive exposure and optimize benefits in the context of phototherapy.


2014 ◽  
Vol 695 ◽  
pp. 139-142 ◽  
Author(s):  
Siti Khairunisah Ghazali ◽  
Nadia Adrus ◽  
Jamarosliza Jamaluddin

Pineapple leaf fibers (PALF) have several advantages such as low cost, eco-friendly, and high specific strength. However, the brittleness of PALF limits its application. To overcome this limitation of PALF, it is essential to synergize the advantages of PALF with elastic properties of hydrogel. In this study, PALF was coated with polyacrylamide (PAAm) hydrogel under direct UV light exposure (UVA>300nm). Prior to this coating, PALF was alkali treated to introduce more OH group on PALF fiber. The main purpose of this study was to investigate the effect of untreated/treated PALF coated PAAm hydrogel on the flexibility of the fiber using tensile measurements. From the results, treated PALF coated PAAm hydrogel showed better results in tensile properties compared to untreated PALF due to the alkali treatment which improved the interfacial adhesion between PAAm hydrogel and fiber surface. In general, this study is precursor for further development in natural fiber coating technology.


2020 ◽  
Vol 64 (5) ◽  
pp. 50405-1-50405-5
Author(s):  
Young-Woo Park ◽  
Myounggyu Noh

Abstract Recently, the three-dimensional (3D) printing technique has attracted much attention for creating objects of arbitrary shape and manufacturing. For the first time, in this work, we present the fabrication of an inkjet printed low-cost 3D temperature sensor on a 3D-shaped thermoplastic substrate suitable for packaging, flexible electronics, and other printed applications. The design, fabrication, and testing of a 3D printed temperature sensor are presented. The sensor pattern is designed using a computer-aided design program and fabricated by drop-on-demand inkjet printing using a magnetostrictive inkjet printhead at room temperature. The sensor pattern is printed using commercially available conductive silver nanoparticle ink. A moving speed of 90 mm/min is chosen to print the sensor pattern. The inkjet printed temperature sensor is demonstrated, and it is characterized by good electrical properties, exhibiting good sensitivity and linearity. The results indicate that 3D inkjet printing technology may have great potential for applications in sensor fabrication.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Sean Swetledge ◽  
Renee Carter ◽  
Rhett Stout ◽  
Carlos E. Astete ◽  
Jangwook P. Jung ◽  
...  

AbstractPolymeric nanoparticles have been investigated as potential delivery systems for therapeutic compounds to address many ailments including eye disease. The stability and spatiotemporal distribution of polymeric nanoparticles in the eye are important regarding the practical applicability and efficacy of the delivery system in treating eye disease. We selected poly(lactic-co-glycolic acid) (PLGA) nanoparticles loaded with lutein, a carotenoid antioxidant associated with eye health, as our model ophthalmic nanodelivery system and evaluated its stability when suspended in various conditions involving temperature and light exposure. We also assessed the ocular biodistribution of the fluorescently labeled nanoparticle vehicle when administered topically. Lutein-loaded nanoparticles were stable in suspension when stored at 4 °C with only 26% lutein release and no significant lutein decay or changes in nanoparticle morphology. When stored at 25 °C and 37 °C, these NPs showed signs of bulk degradation, had significant lutein decay compared to 4 °C, and released over 40% lutein after 5 weeks in suspension. Lutein-loaded nanoparticles were also more resistant to photodegradation compared to free lutein when exposed to ultraviolet (UV) light, decaying approximately 5 times slower. When applied topically in vivo, Cy5-labled nanoparticles showed high uptake in exterior eye tissues including the cornea, episcleral tissue, and sclera. The choroid was the only inner eye tissue that was significantly higher than the control group. Decreased fluorescence in all exterior eye tissues and the choroid at 1 h compared to 30 min indicated rapid elimination of nanoparticles from the eye.


2020 ◽  
Vol 8 (Suppl 3) ◽  
pp. A843-A843
Author(s):  
Michael Wagner ◽  
Megan Othus ◽  
Sandip Patel ◽  
Christopher Ryan ◽  
Ashish Sangal ◽  
...  

BackgroundAngiosarcoma is a rare cancer of endothelial cells that can be aggressive and carries a high mortality. A subset of angiosarcomas are characterized by high tumor mutational burden (TMB) and UV light exposure DNA mutational signature. Isolated case reports have suggested clinical efficacy of immune checkpoint blockade in angiosarcoma; no prospective studies of immune checkpoint inhibition in angiosarcoma have been reported. We report efficacy analysis results for patients with advanced or unresectable angiosarcoma treated with ipilimumab and nivolumab as a cohort of an ongoing phase II study for rare cancers (NCT02834013).MethodsThis is a prospective, open-label, multicenter phase II clinical trial of ipilimumab (1mg/kg IV q6weeks) plus nivolumab (240mg IV q2weeks) for patients with metastatic or unresectable angiosarcoma. Primary endpoint is objective response rate as assessed by RECIST v1.1, including measurable cutaneous disease that can be followed by photography. Secondary endpoints include PFS, OS, stable disease at six months, and toxicity. A two-stage design is used with six patients in the first stage and an additional ten patients in the second stage.ResultsAt data cutoff, 16 patients with angiosarcoma were enrolled. Median age was 68 years (25-81 years). Median number of prior lines of therapy was 2 (0-5). 9 patients had cutaneous primary tumors of any cutaneous site, 7 had non-cutaneous primary tumors. ORR for all patients was 25% (4/16, table 1, figure 1). Subgroup analysis revealed that 60% (3/5) of patients with primary cutaneous tumors of the scalp or face had a confirmed objective response. 6-month PFS was 38%. 75% of patients experienced an adverse event (AE), and 25% experienced a grade 3-4 AE. 68.8% experienced an immune related AE (irAE), and 2 (12.5%) developed grade 3 or 4 irAEs. Grade 3-4 irAEs were ALT and AST increase and diarrhea. There were no grade 5 toxicities.ConclusionsThe combination of ipilimumab and nivolumab was well tolerated and had an ORR of 25% in angiosarcoma regardless of primary site, with 3 of 5 patients with cutaneous tumors of the scalp or face responding. Ipilimumab and nivolumab warrant further investigation in angiosarcoma.AcknowledgementsFunding: National Institutes of Health/National Cancer Institute grant awards CA180888, CA180819, CA180868; and in part by Bristol-Myers Squibb CompanyTrial RegistrationNCT02834013Ethics ApprovalThis study was approved by the NCI CIRB.


Sign in / Sign up

Export Citation Format

Share Document